These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25043464)

  • 1. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.
    Jun G; Asai H; Zeldich E; Drapeau E; Chen C; Chung J; Park JH; Kim S; Haroutunian V; Foroud T; Kuwano R; Haines JL; Pericak-Vance MA; Schellenberg GD; Lunetta KL; Kim JW; Buxbaum JD; Mayeux R; Ikezu T; Abraham CR; Farrer LA
    Ann Neurol; 2014 Sep; 76(3):379-92. PubMed ID: 25043464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
    Panegyres PK; Zafiris-Toufexis K; Kakulas BA
    J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.
    Dong J; Qin W; Wei C; Tang Y; Wang Q; Jia J
    J Alzheimers Dis; 2017; 57(2):613-623. PubMed ID: 28269784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.
    Reitz C; Conrad C; Roszkowski K; Rogers RS; Mayeux R
    Arch Neurol; 2012 Jul; 69(7):894-900. PubMed ID: 22393166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal-specific isoform of BIN1 regulates β-secretase cleavage of APP and Aβ generation in a RIN3-dependent manner.
    Bhattacharyya R; Teves CAF; Long A; Hofert M; Tanzi RE
    Sci Rep; 2022 Mar; 12(1):3486. PubMed ID: 35241726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.
    Stein TD; Anders NJ; DeCarli C; Chan SL; Mattson MP; Johnson JA
    J Neurosci; 2004 Sep; 24(35):7707-17. PubMed ID: 15342738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
    Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
    Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
    Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
    Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.
    Cruchaga C; Kauwe JS; Mayo K; Spiegel N; Bertelsen S; Nowotny P; Shah AR; Abraham R; Hollingworth P; Harold D; Owen MM; Williams J; Lovestone S; Peskind ER; Li G; Leverenz JB; Galasko D; ; Morris JC; Fagan AM; Holtzman DM; Goate AM
    PLoS Genet; 2010 Sep; 6(9):e1001101. PubMed ID: 20862329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).
    Reitz C; Tosto G; Vardarajan B; Rogaeva E; Ghani M; Rogers RS; Conrad C; Haines JL; Pericak-Vance MA; Fallin MD; Foroud T; Farrer LA; Schellenberg GD; George-Hyslop PS; Mayeux R;
    Transl Psychiatry; 2013 May; 3(5):e256. PubMed ID: 23673467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MAPT H1 haplotype is associated with tangle-predominant dementia.
    Santa-Maria I; Haggiagi A; Liu X; Wasserscheid J; Nelson PT; Dewar K; Clark LN; Crary JF
    Acta Neuropathol; 2012 Nov; 124(5):693-704. PubMed ID: 22802095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility for Alzheimer disease neuritic plaque pathology.
    Shulman JM; Chen K; Keenan BT; Chibnik LB; Fleisher A; Thiyyagura P; Roontiva A; McCabe C; Patsopoulos NA; Corneveaux JJ; Yu L; Huentelman MJ; Evans DA; Schneider JA; Reiman EM; De Jager PL; Bennett DA
    JAMA Neurol; 2013 Sep; 70(9):1150-7. PubMed ID: 23836404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Aβ
    Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
    Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.